Community screening for left ventricular systolic dysfunction using plasma and urinary natriuretic peptides
- 1 April 2005
- journal article
- research article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 45 (7) , 1043-1050
- https://doi.org/10.1016/j.jacc.2004.12.058
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Effects of tilting and volume loading on plasma levels and urinary excretion of relaxin, NT-pro-ANP, and NT-pro-BNP in male volunteersJournal of Applied Physiology, 2004
- Cost-effectiveness of screening with B-type natriuretic peptide to identify patients with reduced left ventricular ejection fractionJournal of the American College of Cardiology, 2004
- Diagnosis of heart failure using urinary natriuretic peptidesClinical Science, 2004
- Identification of previously undiagnosed left ventricular systolic dysfunction: community screening using natriuretic peptides and electrocardiographyEuropean Journal of Heart Failure, 2003
- Reliability of N-terminal pro-brain natriuretic peptide assay in diagnosis of heart failure: cohort study in representative and high risk community populationsBMJ, 2002
- ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summaryJournal of the American College of Cardiology, 2001
- Guidelines for the diagnosis and treatment of chronic heart failureEuropean Heart Journal, 2001
- Differential expression and synthesis of natriuretic peptides determines natriuretic peptide receptor expression in primary cultures of human proximal tubular cellsJournal Of Hypertension, 2001
- Biochemical detection of left-ventricular systolic dysfunctionThe Lancet, 1998
- Urinary immunoreactive brain natriuretic peptide in patients with renal diseaseRegulatory Peptides, 1996